Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Discontinued Operations: 2018-2025

Historic Cash from Discontinued Operations for Pediatrix Medical (MD) over the last 8 years, with Q3 2025 value amounting to -$830000.0.

  • Pediatrix Medical's Cash from Discontinued Operations rose 7864.68% to -$830000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year increase of 6083.25%. This contributed to the annual value of -$10.7 million for FY2024, which is 2193.92% down from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's Cash from Discontinued Operations is -$830000.0, which was up 7864.68% from -$964000.0 recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Cash from Discontinued Operations peaked at $16.7 million during Q1 2021, and registered a low of -$30.8 million during Q4 2021.
  • Over the past 5 years, Pediatrix Medical's median Cash from Discontinued Operations value was -$2.6 million (recorded in 2024), while the average stood at -$3.9 million.
  • Its Cash from Discontinued Operations has fluctuated over the past 5 years, first surged by 10480.57% in 2022, then tumbled by 85311.36% in 2024.
  • Pediatrix Medical's Cash from Discontinued Operations (Quarter) stood at -$30.8 million in 2021, then soared by 88.29% to -$3.6 million in 2022, then fell by 4.05% to -$3.8 million in 2023, then soared by 52.17% to -$1.8 million in 2024, then skyrocketed by 53.76% to -$830000.0 in 2025.
  • Its Cash from Discontinued Operations stands at -$830000.0 for Q3 2025, versus -$964000.0 for Q2 2025 and -$1.4 million for Q1 2025.